Elanco has announced that Baycox Iron is available again, following the company’s acquisition of Bayer Animal Health in 2020.
Louise Radford, marketing manager at Elanco, said the ‘time-saving flexible dosing treatment’ offers a solution to the impact of coccidiosis in piglets that complements the company’s existing piglet gut health portfolio.
“Baycox Iron is an injectable treatment used to prevent both clinical coccidiosis and iron deficiency in piglets,” she said.
“By treating piglets at two or three days old, it’s possible to allow enough exposure to the coccidiosis parasite to enable them to develop natural immunity, while preventing any damage to the gut caused by subclinical and clinical coccidiosis which leads to poor growth and low weaning weights.
“By combining treatments, it’s possible to limit the number of times they are handled, which in turn reduces stress and enhances growth,” she adds.
Elanco already specialises in promoting piglet gut health, with its Coliprotec vaccine providing protection against post weaning diarrhoea (PWD).
“As farmers and vets prepare for the removal of zinc oxide as a treatment option next year, focusing on gut health throughout all stages of development has never been more crucial,” Ms Radford said.
“Baycox Iron is a treatment used in the early stages in life. It helps get piglets off on the right foot, setting them up to thrive by reducing any potential gut damage caused by coccidiosis, and contributing towards good growth and weaning weights,” she added.